Safety of buprenorphine transdermal system in the management of pain in older adults

References

• Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Practice. 2008;8:287–313.
   PubMedGoogle Scholar
• Kaye AD, Baluch AR, Kaye RJ, et al. Geriatric pain management, pharmacological and nonpharmacological considerations. Psychol Neurosci. 2014;7:15–26.
   Google Scholar
• Pimentel CB, Briesacher BA, Gurwitz JH, et al. Pain management in nursing home residents with cancer. J Am Geriatr Soc. 2015;63:633–641.
   PubMed Web of Science ®Google Scholar
• Hallenbeck J. Pain management in American nursing homes – a long way to go. J Am Geriatric Soc. 2015;63:642–643.
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological Management of Persistent Pain in Older Persons. J Am Geriatr Soc. 2009;57:1331–1346.
   PubMed Web of Science ®Google Scholar
• Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010;27:417–433.
   PubMed Web of Science ®Google Scholar
• Chau DL, Walker V, Pai L, et al. Opiates and elderly: use and side effects. Clin Interv Aging. 2008;3:273–278.
   PubMed Web of Science ®Google Scholar
• Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review. J Pain. 2002;3:159–180.
   PubMed Web of Science ®Google Scholar
• Miller M, Sturmer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc. 2011;59:430–438.
   PubMed Web of Science ®Google Scholar
• Rolita L, Spegman A, Tang X, et al. Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc. 2013;61:335–340.
   PubMed Web of Science ®Google Scholar
• FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use [FDA website]. August 31, 2016. [cited 2016 Dec 12]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm518697.htm.
   Google Scholar
• CDC guideline, Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
   Web of Science ®Google Scholar
• Johnson RE, Fudala PJ, Payne R. Buprenorphine: considerations for pain management. J Pain Sympt Manage. 2005;29:297–326.
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Aloisi AM, Dahan A, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Practice. 2010;10:428–450.
   PubMed Web of Science ®Google Scholar
• Butrans [Full Prescribing Information]. Stamford, CT; Purdue Pharma L.P., 2014. [cited 2016 Dec 12]. Available from: http://app.purduepharma.com/xmlpublishing/pi.aspx?id=b.
   Google Scholar
• Steiner D, Munera C, Hale M, et al. Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study. J Pain. 2011;12(11):1163–1173.
   PubMed Web of Science ®Google Scholar
• Steiner DJ, Sitar S, Wen W, et al. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naive patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study. J Pain Symptom Manag. 2011;42(6):903–917.
   PubMed Web of Science ®Google Scholar
• Gordon A, Callaghan D, Spink D, et al. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther. 2010;32(5):844–860.
   PubMed Web of Science ®Google Scholar
• Gordon A, Rashiq S, Moulin DE, et al. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res Manag. 2010;15(3):169–178.
   PubMed Web of Science ®Google Scholar
• Munera C, Drehobl M, Sessler NE, et al. A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis. J Opioid Manag. 2010;6(3):193–202.
   PubMedGoogle Scholar
• Landau CJ, Carr WD, Razzetti AJ, et al. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study. Clin Ther. 2007;29(10):2179–2193.
   PubMed Web of Science ®Google Scholar
• Karlsson J, Söderström A, Augustini BG, et al. Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study. Curr Med Res Opin. 2014;30:575–587.
   PubMed Web of Science ®Google Scholar
• Conaghan PG, O’Brien CM, Wilson M, et al. Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and/or knee: a randomised trial. Osteoarthr Cartil. 2011;19(8):930–938.
   PubMed Web of Science ®Google Scholar
• Husebo BS, Ballard C, Sandvik R, et al. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. BMJ. 2011;343:d4065.
   PubMed Web of Science ®Google Scholar
• Sandvik RK, Selbaek G, Seifert R, et al. Impact of a stepwise protocol for treating pain on pain intensity in nursing home patients with dementia: a cluster randomized trial. Eur J Pain. 2014;18:1490–1500.
   PubMed Web of Science ®Google Scholar
• Uberall MA, Muller-Schwefe GHH. Low-dose 7-day transdermal buprenorphine in daily clinical practice – perceptions of elderly patients with moderate non-malignant chronic pain. Curr Med Res Opin. 2012;28(10):1585–1595.
   PubMed Web of Science ®Google Scholar
• SAS. [cited 2016 Dec 12]. Available from: http://support.sas.com/index.html.
   Google Scholar
• Electronic code of federal regulations: title 21 food and drugs. [cited 2016 Dec 12]. Available from: http://www.ecfr.gov/cgi-bin/text-idx?SID=3ee286332416f26a91d9e6d786a604ab&mc=true&tpl=/ecfrbrowse/Title21/21tab_02.tpl.
   Google Scholar
• Viswanathan A, Sudarsky L. Balance and gait problems in the elderly. Handb Clin Neurol. 2012;103:623–634.
   PubMedGoogle Scholar
• Walker-Bone K. Preventing fractures in the elderly. Br J Hosp Med. 2011;72(10):576–581.
   Web of Science ®Google Scholar
• Wetmore SJ, Eibling DE, Goebel JA, et al. Challenges and opportunities in managing the dizzy older adult. Otolaryngol Head Neck Surg. 2011;144(5):651–656.
   PubMed Web of Science ®Google Scholar
• Barin K, Dodson EE. Dizziness in the elderly. Otolaryngol Clin North Am. 2011;44(2):437–454.
   PubMed Web of Science ®Google Scholar
• Kragh A, Elmståhl S, Atroshi I. Older adults’ medication use 6 months before and after hip fracture: a population –based cohort study. J Am Geriatric Soc. 2011;59:863–868.
   PubMed Web of Science ®Google Scholar
• Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with the use of morphine and opiates. J Intern Med. 2006;260:76–87.
   PubMed Web of Science ®Google Scholar
• Hass B, Lungershausen J, Hertel N, et al. Cost-effectiveness of strong opioids focussing on the long-term effects of opioid-related fractures: a model approach. Eur J Health Econ. 2009;10:309–321.
   PubMed Web of Science ®Google Scholar
• Hirst A, Knight C, Hirst M, et al. Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine. Eur J Health Econ. 2016;17:217–227.
   PubMed Web of Science ®Google Scholar
• Hegeman J, van den Bemt BJ, Duysens J, et al. NSAIDs and the risk of accidental falls in the elderly: a systematic review. Drug Saf. 2009;32:489–498.
   PubMed Web of Science ®Google Scholar
• Walker PC, Alrawi A, Mitchell JF, et al. Medication use as a risk factor for falls among hospitalized elderly patients. Am J Health-System Pharm. 2005;62:2495–2499.
   PubMed Web of Science ®Google Scholar
• Huang AR, Mallet L, Rochefort CM, et al. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29:359–376.
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system – active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50:1629–1637.
   PubMed Web of Science ®Google Scholar
• Atkinson TJ, Fudin J, Pandula A, et al. Medication pain management in the elderly: unique and underutilized analgesic treatment options. Clin Ther. 2013;35:1669–1689.
   PubMed Web of Science ®Google Scholar